Building companies, accelerating development.
Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology. Through its expertise and network, Genesys accelerates the development of commercially viable emerging companies that represent promising life science investment opportunities.
Investor Login
Sign in to our secure investor area to receive personalized updates and information. Login now »
Recent Additions
- Affinium Pharmaceuticals, Ltd. Announces Initiation of a Phase I Clinical Trial for AFN-1252
- Austin, TX and Toronto, ON (March 4, 2008) Affinium Pharmaceuticals today announced that they have commenced the dosing of... Read more
- Insception Biosciences Begins Human Clinical Trials of Stem Cell Treatment That Could Replace Bone Marrow Transplants
- Toronto, ON (February 6, 2008) Insception Biosciences Inc., a privately-held company that develops stem cell treatments, announced today it has... Read more
